Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Income Statement [Abstract]
REVENUES, NET	$ 30,842,545	$ 28,353,779	$ 61,896,857	$ 53,634,563
COST OF GOODS SOLD	23,829,793	21,660,415	46,903,886	40,879,761
GROSS PROFIT	7,012,752	6,693,364	14,992,971	12,754,802
SELLING EXPENSES	6,475,512	6,485,848	12,747,919	12,454,399
GENERAL AND ADMINISTRATIVE EXPENSES	2,061,559	1,823,935	4,181,725	4,675,547
TOTAL OPERATING EXPENSES	8,537,071	8,309,783	16,929,644	17,129,946
LOSS FROM OPERATIONS	(1,524,319)	(1,616,419)	(1,936,673)	(4,375,144)
OTHER INCOME (EXPENSE):
INTEREST INCOME	187,667	340,514	351,255	388,387
INTEREST EXPENSE	(117,692)		(245,079)
OTHER	(124,496)	(72,225)	(74,475)	(134,710)
CHANGE IN FAIR VALUE OF DERIVATIVE LIABILITIES	32,674	6,865	27,784	410,420
LOSS BEFORE INCOME TAXES	(1,546,166)	(1,341,265)	(1,877,188)	(3,711,047)
PROVISION FOR INCOME TAXES	(18,975)	5,702	38,595	14,090
NET LOSS	(1,527,191)	(1,346,967)	(1,915,783)	(3,725,137)
LESS: NET LOSS ATTRIBUTABLE TO NONCONTROLLING INTEREST	(33,472)	(122,004)	(190,555)	(365,223)
NET LOSS ATTRIBUTABLE TO CHINA JO-JO DRUGSTORES, INC.	(1,493,719)	(1,224,963)	(1,725,228)	(3,359,914)
Foreign currency translation adjustments	1,031,461	(536,335)	1,125,030	(941,573)
COMPREHENSIVE LOSS	$ (495,730)	$ (1,883,302)	$ (790,753)	$ (4,666,710)
WEIGHTED AVERAGE NUMBER OF SHARES:
Basic	37,961,790	32,936,786	36,232,144	32,696,348
Diluted	37,961,790	32,936,786	36,232,144	32,696,348
EARNINGS PER SHARES:
Basic	$ (0.04)	$ (0.04)	$ (0.05)	$ (0.10)
Diluted	$ (0.04)	$ (0.04)	$ (0.05)	$ (0.10)